The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

JCN Chan, LL Lim, NJ Wareham, JE Shaw, TJ Orchard… - The Lancet, 2020 - thelancet.com
Executive summary 2020 will go down in history as the year when the global community was
awakened to the fragility of human health and the interdependence of the ecosystem …

[HTML][HTML] Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.

K Winkley, R Upsher, D Stahl, D Pollard… - Health technology …, 2020 - ncbi.nlm.nih.gov
BACKGROUND For people with diabetes mellitus to achieve optimal glycaemic control,
motivation to perform self-management is important. The research team wanted to determine …

First-line therapy for type 2 diabetes with sodium–glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a cost-effectiveness study

JG Choi, AN Winn, MR Skandari, MI Franco… - Annals of internal …, 2022 - acpjournals.org
Background: Guidelines recommend sodium–glucose cotransporter-2 (SGLT2) inhibitors
and glucagon-like peptide-1 (GLP1) receptor agonists as second-line therapy for patients …

State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force–3

U Siebert, O Alagoz, AM Bayoumi… - Medical Decision …, 2012 - journals.sagepub.com
State-transition modeling (STM) is an intuitive, flexible, and transparent approach of
computer-based decision-analytic modeling, including both Markov model cohort simulation …

Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch study of intensive …

WH Herman, W Ye, SJ Griffin, RK Simmons… - Diabetes …, 2015 - Am Diabetes Assoc
OBJECTIVE To estimate the benefits of screening and early treatment of type 2 diabetes
compared with no screening and late treatment using a simulation model with data from the …

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United …

AJ Hayes, J Leal, AM Gray, RR Holman, PM Clarke - Diabetologia, 2013 - Springer
Aims/hypothesis The aim of this project was to build a new version of the United Kingdom
Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS-OM1), a patient-level …

[图书][B] Applied methods of cost-effectiveness analysis in healthcare

AM Gray, PM Clarke, JL Wolstenholme, S Wordsworth - 2010 - books.google.com
The third volume in the Handbooks in Health Economic Evaluation series, this book
provides the reader with a comprehensive set of instructions and examples of how to …

The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities

MT Schram, SJS Sep, CJ Van Der Kallen… - European journal of …, 2014 - Springer
Abstract The Maastricht Study is an extensive phenotyping study that focuses on the etiology
of type 2 diabetes (T2DM), its classic complications, and its emerging comorbidities. The …

[HTML][HTML] Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization

BA Young, E Lin, M Von Korff, G Simon… - The American journal …, 2008 - ncbi.nlm.nih.gov
Diabetes Complications Severity Index and Risk of Mortality, Hospitalization, and Healthcare
Utilization - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

Validating the adapted Diabetes Complications Severity Index in claims data.

HY Chang, JP Weiner, TM Richards… - The American journal …, 2012 - europepmc.org
Validating the adapted Diabetes Complications Severity Index in claims data. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …